Avidity Biosciences RNA

$ 43.11 1.29%

Quarterly report 2024-Q3
added 11-07-2024

Avidity Biosciences Financial Statements 2011-2024 | RNA

Annual Financial Statements Avidity Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.1 B	1.25 B	703 M	523 M	-	-	-	-	-	-	-	-	-
Shares	73 M	52.2 M	41.4 M	21.7 M	-	-	-	-	-	-	-	-	-
Historical Prices	15.1	24	17	24.1	-	-	-	-	-	-	-	-	-
Net Income	-212 M	-174 M	-118 M	-44.4 M	-24.7 M	-11.2 M	-	-	-	-	-	-	-
Revenue	9.56 M	9.22 M	9.33 M	6.79 M	2.32 M	379 K	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-236 M	-179 M	-118 M	-44.3 M	-17.3 M	-10.5 M	-	-	-	-	-	-	-
Interest Expense	-594 K	-57 K	-62 K	209 K	7.39 M	718 K	-	-	-	-	-	-	-
EBITDA	-233 M	-178 M	-117 M	-43.9 M	-17 M	-10.1 M	-	-	-	-	-	-	-
Operating Expenses	245 M	188 M	127 M	51.1 M	19.7 M	10.9 M	-	-	-	-	-	-	-
General and Administrative Expenses	54.2 M	37.7 M	26.2 M	13.5 M	5.11 M	2.44 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Avidity Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	123 M	107 M	87.2 M	79.3 M	74.1 M	71.4 M	70.4 M	69.8 M	53.1 M	49.9 M	48.2 M	47.8 M	43.3 M	37.6 M	37.5 M	37.6 M	37.4 M	8.59 M	2.84 M	2.99 M	2.74 M	2.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-80.4 M	-70.8 M	-68.9 M	-	-52.4 M	-47 M	-52.4 M	-	-43.6 M	-45.7 M	-34.2 M	-	-29.3 M	-26.4 M	-23.8 M	-16.3 M	-11.4 M	-10.6 M	-6.08 M	-10.4 M	-6.67 M	-5.12 M	-2.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	2.34 M	2.04 M	3.54 M	-	2.82 M	2.32 M	2.23 M	-	2.48 M	2.18 M	1.8 M	-	2.16 M	2.61 M	2.7 M	2.14 M	1.75 M	1.54 M	1.36 M	1.44 M	650 K	224 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-98.1 M	-82.6 M	-77.2 M	-	-58.6 M	-52.6 M	-57.6 M	-	-44.9 M	-46.3 M	-34.5 M	-	-29.3 M	-26.4 M	-23.9 M	-	-11.5 M	-10.4 M	-6.15 M	-	-5.21 M	-3.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-232 K	-116 K	-101 K	-	-13 K	-162 K	-314 K	-	-12 K	-2 K	-25 K	-	-11 K	-2 K	-	-	-	131 K	78 K	-	1.46 M	1.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-97.4 M	-81.9 M	-76.5 M	-	-58 M	-52.1 M	-57.2 M	-	-44.5 M	-46 M	-34.1 M	-	-29.1 M	-26.3 M	-23.7 M	-	-11.4 M	-10.3 M	-6.07 M	-	-4.94 M	-3.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	100 M	84.7 M	80.7 M	-	61.4 M	55 M	59.8 M	-	47.4 M	48.5 M	36.3 M	-	31.4 M	29 M	26.6 M	18.4 M	13.2 M	11.9 M	7.51 M	7.49 M	5.86 M	4.13 M	2.17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	23.3 M	20.7 M	13.9 M	-	13.7 M	12.3 M	12.1 M	-	10.1 M	8.69 M	8.57 M	-	6.61 M	6.27 M	5.88 M	-	3.76 M	2.92 M	1.96 M	-	757 K	1.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency